CNS Pharmaceuticals Inc (CNSP)

[StockLogistics]

“Trial record 1 of 1 for: NCT04762069
Previous Study | Return to List | Next Study
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04762069
Recruitment Status : Recruiting
First Posted : February 21, 2021
Last Update Posted : May 20, 2022
See Contacts and Locations
Sponsor:
CNS Pharmaceuticals, Inc.
Collaborator:
Worldwide Clinical Trials
Information provided by (Responsible Party):
CNS Pharmaceuticals, Inc.

Study DetailsTabular View No Results PostedDisclaimerHow to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2024
Estimated Study Completion Date : February 2025”